Melanoma drug expensive for NSH

Posted by admin | On: Jun 15 2012


NHS has stopped supplying melanoma drug after looking at the cost and the long term benefits of the drug. The drug is to be costing the NHS £1,750 a week and this is after the company that made is reduced the price.

This is not the first time NHS has refused to sell a drug this year; ipilimumab was also off NHS shelves after still showing that half of the patients taking it were still alive after 3 years.

“This is another truly devastating blow to all melanoma patients and their families, many of whom are very young and with young families. Said Gill Nuttall CEO of melanoma.

Sir Andrew Dillon, chief executive of Nice said: “We need to be sure that new treatments provide sufficient benefits to patients to justify the significant cost the NHS is being asked to pay. Nice is the company that looks at all the drugs that are in producing and to be sold by the NHS.





comment closed